Learn More
Enzo Life Sciences trans-Ned-19 (0.5mg)

Supplier: Enzo Life Sciences ALX270503MC05
Cell permeable, selective and potent inhibitor of nicotinic acid adenine dinucleotide phosphate (NAADP) receptor in mammalian cells and sea urchin eggs. Blocks NAADP signaling. Inhibits Ca2+ release: trans-Ned-19 (IC50 = 6nM); cis-Ned-19 (IC50 = 800nM). [32P] NAADP binding: trans-Ned-19 (IC50 = 0.4nM); cis-Ned-19 (IC50 = 15µM).Inhibits Ca2+ release from lysosomes. Noncompetitive antagonist. Fluorescent. Alternative name: 1-(3-((4-(2-Fluorophenyl)piperazin-1-yl)methyl)-4-methoxyphenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid. Purity: ≥97% (HPLC). Appearance: White to off-white powder. Solubility: Soluble in DMSO or 100% ethanol. Long Term Storage: -20°C.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.